Guru Ownership Trend
Guru Analysis for Puma Biotechnology, Inc. (PBYI)
Puma Biotechnology, Inc. (PBYI), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $23.67 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.47 M net outflow during the quarter.
On the selling side, Cliff Asness reduced exposure by 9.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Puma Biotechnology, Inc. (PBYI)
Major holders include Renaissance Technologies (RenTech) ($14.89 M), Cliff Asness ($5.88 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 2.56 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.47 M, with 0 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited PBYI. The total reported sell value was $1.47 M.
No tracked managers opened new positions or increased their holdings in PBYI during the most recent reporting period.